Bio-Thera Solutions Partners with Tabuk Pharmaceuticals to Commercialize BAT2206, a Stelara® (Ustekinumab) Biosimilar in Saudi Arabia ...Middle East

GUANGZHOU, China, Dec. 24, 2024 /PRNewswire/ -- Bio-Thera Solutions Inc. (688177:SH), a commercial-stage biopharmaceutical company developing a pipeline of innovative therapies and a pipeline of biosimilars, today announced the company has partnered with Tabuk Pharmaceutical Manufacturing...

Hence then, the article about bio thera solutions partners with tabuk pharmaceuticals to commercialize bat2206 a stelara ustekinumab biosimilar in saudi arabia was published today ( Tuesday 24/12/2024 - 03:22 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Bio-Thera Solutions Partners with Tabuk Pharmaceuticals to Commercialize BAT2206, a Stelara® (Ustekinumab) Biosimilar in Saudi Arabia )

Also on site :

• Russian oil supplies to India surge – media
• Prime Video Touts India as ‘Most Important’ Global Market
• Meet Mark Zuckerberg’s college roommate. He’s an Olympian-turned-VC exec who now invests in your favorite celebrity businesses